|
41 |
Developments in the clinical understanding of rheumatoid arthritis
Enthalten in Arthritis Research & Therapy Bd. 11, 30.1.2009, Nr. 1, date:2.2009: 1-9
|
|
|
|
42 |
Differences and similarities in clinical and functional responses among patients receiving tofacitinib monotherapy, tofacitinib plus methotrexate, and adalimumab plus methotrexate: a post hoc analysis of data from ORAL Strategy
Enthalten in Arthritis Research & Therapy Bd. 23, 24.8.2021, Nr. 1, date:12.2021: 1-11
|
|
|
|
43 |
Discordance between patient and physician assessments of global disease activity in rheumatoid arthritis and association with work productivity
Enthalten in Arthritis Research & Therapy Bd. 18, 21.5.2016, Nr. 1, date:12.2016: 1-11
|
|
|
|
44 |
Disease activity improvements with optimal discriminatory ability between treatment arms: applicability in early and established rheumatoid arthritis clinical trials
Enthalten in Arthritis Research & Therapy Bd. 21, 10.11.2019, Nr. 1, date:12.2019: 1-8
|
|
|
|
45 |
Dorso-ventral osteophytes of interphalangeal joints correlate with cartilage damage and synovial inflammation in hand osteoarthritis: a histological/radiographical study
Enthalten in Arthritis Research & Therapy Bd. 24, 29.9.2022, Nr. 1, date:12.2022: 1-9
|
|
|
|
46 |
Effects of a brief workplace-centered consultation for employees with musculoskeletal pain on health outcomes: a prospective cohort study
Enthalten in Scientific reports Bd. 9, 10.4.2019, Nr. 1, date:12.2019: 1-10
|
|
|
|
47 |
Efficacy and Safety of Ixekizumab with or Without Methotrexate in Biologic-Naïve Patients with Psoriatic Arthritis: 52-Week Results from SPIRIT-H2H Study
Enthalten in Rheumatology and therapy Bd. 7, 16.11.2020, Nr. 4, date:12.2020: 1021-1035
|
|
|
|
48 |
Erinnerungen an Winfried Graninger
Enthalten in Zeitschrift für Rheumatologie Bd. 82, 20.7.2023, Nr. 6, date:8.2023: 532-534
|
|
|
|
49 |
Erratum to: Interleukin-6: a new therapeutic target
Enthalten in Arthritis Research & Therapy Bd. 8, 17.10.2006, Nr. 6, date:12.2006: 1
|
|
|
|
50 |
Evaluation of newly proposed remission cut-points for disease activity score in 28 joints (DAS28) in rheumatoid arthritis patients upon IL-6 pathway inhibition
Enthalten in Arthritis Research & Therapy Bd. 19, 4.7.2017, Nr. 1, date:12.2017: 1-6
|
|
Administration
